5409

Medico Remedies Stock Price

Symbol: BSE:540937Market Cap: ₹3.3bCategory: Pharmaceuticals & Biotech

540937 Share Price Performance

Community Fair Values

    Recent 540937 News & Updates

    No updates

    Medico Remedies Limited Key Details

    ₹1.5b

    Revenue

    ₹1.1b

    Cost of Revenue

    ₹426.1m

    Gross Profit

    ₹325.2m

    Other Expenses

    ₹100.9m

    Earnings

    Last Reported Earnings
    Mar 31, 2025
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    1.22
    Gross Margin
    28.23%
    Net Profit Margin
    6.69%
    Debt/Equity Ratio
    22.1%

    Medico Remedies Limited Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About 540937

    Founded
    1994
    Employees
    193
    CEO
    Harshit Mehta
    WebsiteView website
    medicoremedies.com

    Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and steroidal preparations. It exports its products. Medico Remedies Limited was incorporated in 1994 and is based in Mumbai, India.

    Indian Market Performance

    • 7 Days: -1.8%
    • 3 Months: 5.5%
    • 1 Year: -6.0%
    • Year to Date: -0.3%
    Over the last 7 days, the market has dropped 1.8%, driven by a loss of 2.7% in the Financials sector. In the last 12 months the market is down 6.0%. Earnings are forecast to grow by 15% annually. Market details ›
    Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
    Continue reading